Collectively, understanding the multifaceted involvement of RANGAP1 in glioma pathogenesis offers valuable insights for targeted interventions and enhances our comprehension of glioma progression and treatment strategies. This evidence concerns the gene RANGAP1 and central nervous system cancer.